Related Articles
Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines
Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor‑κB activity in human oral cancer cells
Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity